Accession	SAMC3041010
Accession in Other Database	GSA-Human: HRS911420
Sample name	T530290d6
Title	RNA Tumor of D00052
Sample type	Human sample
Organism	Homo sapiens
Description	RNA data: Paraffin section of surgically resected tumor from Tumor tissue
Attributes	*This sample record contains additional controlled-access information that is avaiable from GSA-Human by requesting study HRA005236 in the GSA-Human system.
Release date	2023-09-01
BioProject Accession	PRJCA018782
Submitter	Zhiyong Qin (qinzhiyong@fudan.edu.cn)
Organization	Huashan Hospital Fudan University
Submission date	2023-09-02

Sample Data

Resource name	Description
GSA-Human (1)	-
HRA005236 (Controlled Access)	Only fewer than 5% GBM patients survive over 5 years and referred as long-term survivors (LTS), yet the underlying molecular background of these LTS are insufficiently understood. Herein, we employed comprehensive whole exome sequencing (WES), RNA-seq and methylation array to delineate molecular landscape of the largest LTS cohort to date. Our cohort consisted of 78 primary GBM patients and were divided into LTS (n = 37) and short-term survivors (STS, OS <= 24 months, n = 41), all confirmed being isocitrate dehydrogenase (IDH)-wildtype. These is the raw data of WES, RNAseq, and Bisulfite sequencing of the project.

Resource name

Description

GSA-Human (1)

HRA005236 (Controlled Access)

Only fewer than 5% GBM patients survive over 5 years and referred as long-term survivors (LTS), yet the underlying molecular background of these LTS are insufficiently understood. Herein, we employed comprehensive whole exome sequencing (WES), RNA-seq and methylation array to delineate molecular landscape of the largest LTS cohort to date. Our cohort consisted of 78 primary GBM patients and were divided into LTS (n = 37) and short-term survivors (STS, OS <= 24 months, n = 41), all confirmed being isocitrate dehydrogenase (IDH)-wildtype. These is the raw data of WES, RNAseq, and Bisulfite sequencing of the project.

Related samples

Samples (2)